RNA‐Seq Transcriptome Analysis of Differentiated Human Oligodendrocytic MO3.13 Cells Shows Upregulation of Genes Involved in Myogenesis

Abstract

In this work, we examined the differentiation of oligodendrocytic MO3.13 cells and changes in their gene expression after treatment with phorbol 12‐myristate 13‐acetate, PMA, or with RNA polymerase I (Pol I) inhibitor, CX‐5461. We found that MO3.13 cells changed their morphology when treated with both agents. Interestingly, CX‐5461, but not PMA, induced no-ticeable changes in the integrity of the nucleoli. Then, we analyzed the p53 transcriptional activity in MO3.13 cells and found that it was increased in both cell populations, but particularly in cells treated with PMA. Interestingly, this high p53 transcriptional activity in PMA‐treated cells coin-cided with a lower level of an unmodified (non‐phosphorylated) form of this protein. Since mor-phological changes in MO3.13 cells after PMA and CX‐5461 treatment were evident, suggesting that cells were induced to differentiate, we performed RNA‐seq analysis of PMA‐treated cells, to reveal the direction of alterations in gene expression. The analysis showed that the largest group of upregulated genes consisted of those involved in myogenesis and K‐RAS signaling, rather than those associated with oligodendrocyte lineage progression.